ROBERT NELSEN Insider Trading Transactions
Get free email notifications about insider trading for ROBERT NELSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT NELSEN. ROBERT NELSEN is in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Unity Biotechnology, Inc. ($UBX) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Juno Therapeutics, Inc. ($JUNO) and Director in Bellerophon Therapeutics, Inc. ($BLPH) and Director in Sage Therapeutics, Inc. ($SAGE) and in Sienna Biopharmaceuticals, Inc. ($SNNA) and Director in Sienna Biopharmaceuticals, Inc. ($SNNA) and Director in Denali Therapeutics Inc. ($DNLI) and Director in Vir Biotechnology, Inc. ($VIR) and Director in Beam Therapeutics Inc. ($BEAM) and in Karuna Therapeutics, Inc. ($KRTX) and Director in Karuna Therapeutics, Inc. ($KRTX) and Director in Lyell Immunopharma, Inc. ($LYEL) and Director in Sana Biotechnology, Inc. ($SANA).
Latest Insider Trading Transactions of ROBERT NELSEN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, BEAM, BLPH, DNLI, JUNO, KRTX, KYTH, LYEL, SAGE, SANA, SNNA, SYRS, UBX, VIR
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 435,142 | 0 | 0 | |
Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 435,142 | 0 | 0 | |
Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 17,771,216 | 0 | 0 | |
Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 17,771,216 | 0 | 0 | |
Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 18,206,358 | 0 | 18,206,358 | 0 to 18.2 M |
Jun 23 2021 | LYEL | Lyell Immunopharma ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 18,206,358 | 0 | 18,206,358 | 0 to 18.2 M |
Apr 27 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Apr 27 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Apr 15 2021 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 1,756 | 0 | 5,269 | 3.5 K to 5.3 K (+49.99 %) |
Apr 15 2021 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 75,000 | 0 | 1,456,435 | 1.5 M to 1.5 M (-4.90 %) |
Apr 15 2021 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 75,000 | 0 | 1,456,437 | 1.5 M to 1.5 M (-4.90 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 5,989 | 0 | 23,954 | 18 K to 24 K (+33.34 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 282,219 | 0 | 15,051,678 | 15.3 M to 15.1 M (-1.84 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 217,781 | 0 | 11,614,985 | 11.8 M to 11.6 M (-1.84 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 5,989 | 0 | 17,965 | 12 K to 18 K (+50.01 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 282,219 | 0 | 15,333,897 | 15.6 M to 15.3 M (-1.81 %) |
Apr 09 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 217,781 | 0 | 11,832,766 | 12.1 M to 11.8 M (-1.81 %) |
Apr 02 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 4,686 | 0 | 14,053 | 9.4 K to 14.1 K (+50.03 %) |
Apr 02 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 200,000 | 0 | 3,521,519 | 3.7 M to 3.5 M (-5.37 %) |
Apr 02 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 200,000 | 0 | 3,521,520 | 3.7 M to 3.5 M (-5.37 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 5,987 | 0 | 11,976 | 6 K to 12 K (+99.97 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 282,219 | 0 | 15,616,116 | 15.9 M to 15.6 M (-1.78 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 217,781 | 0 | 12,050,547 | 12.3 M to 12.1 M (-1.78 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 5,989 | 0 | 5,989 | 0 to 6 K |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 282,219 | 0 | 15,898,335 | 16.2 M to 15.9 M (-1.74 %) |
Apr 01 2021 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 217,781 | 0 | 12,268,328 | 12.5 M to 12.3 M (-1.74 %) |
Mar 22 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 4,684 | 0 | 9,367 | 4.7 K to 9.4 K (+100.02 %) |
Mar 22 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 200,000 | 0 | 3,721,519 | 3.9 M to 3.7 M (-5.10 %) |
Mar 22 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 200,000 | 0 | 3,721,520 | 3.9 M to 3.7 M (-5.10 %) |
Mar 22 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 4,683 | 0 | 4,683 | 0 to 4.7 K |
Mar 22 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 200,000 | 0 | 3,921,519 | 4.1 M to 3.9 M (-4.85 %) |
Mar 22 2021 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 200,000 | 0 | 3,921,520 | 4.1 M to 3.9 M (-4.85 %) |
Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,343,750 | 0 | 0 | |
Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,343,750 | 0 | 0 | |
Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 781,250 | 0 | 0 | |
Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 781,250 | 0 | 0 | |
Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 5,687,500 | 0 | 0 | |
Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 9,375,000 | 0 | 0 | |
Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 9,375,000 | 0 | 0 | |
Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 5,687,500 | 0 | 0 | |
Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 3,687,500 | 0 | 0 | |
Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 3,687,500 | 0 | 0 | |
Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 11,718,750 | 0 | 11,718,750 | 0 to 11.7 M |
Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 11,718,750 | 0 | 11,718,750 | 0 to 11.7 M |
Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 10,156,250 | 0 | 10,301,250 | 145 K to 10.3 M (+7,004.31 %) |
Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 10,156,250 | 0 | 10,303,750 | 147.5 K to 10.3 M (+6,885.59 %) |
Feb 05 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | A | 25.00 | 14,000 | 350,000 | 14,000 | |
Jan 12 2021 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 1,756 | 0 | 3,513 | 1.8 K to 3.5 K (+99.94 %) |
Jan 12 2021 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 75,000 | 0 | 1,531,435 | 1.6 M to 1.5 M (-4.67 %) |
Jan 12 2021 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 75,000 | 0 | 1,531,437 | 1.6 M to 1.5 M (-4.67 %) |
Jan 12 2021 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 1,756 | 0 | 3,513 | 1.8 K to 3.5 K (+99.94 %) |
Jan 12 2021 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 75,000 | 0 | 1,531,435 | 1.6 M to 1.5 M (-4.67 %) |
Jan 12 2021 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 75,000 | 0 | 1,531,437 | 1.6 M to 1.5 M (-4.67 %) |
Nov 16 2020 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 1,757 | 0 | 1,757 | 0 to 1.8 K |
Nov 16 2020 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 75,000 | 0 | 1,606,435 | 1.7 M to 1.6 M (-4.46 %) |
Nov 16 2020 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 75,000 | 0 | 1,606,437 | 1.7 M to 1.6 M (-4.46 %) |
Jun 22 2020 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Option Exercise | A | 9.14 | 25,000 | 228,500 | 25,000 | |
Jun 08 2020 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Option Exercise | A | 97.59 | 12,500 | 1,219,875 | 12,500 | ||
Jun 05 2020 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | A | 0.00 | 3,253 | 0 | 3,253 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | A | 28.82 | 15,183 | 437,574 | 15,183 | |
May 26 2020 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | A | 37.06 | 28,888 | 1,070,589 | 28,888 | |
Feb 11 2020 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 33,184 | 0 | 0 | |
Feb 11 2020 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 33,184 | 0 | 0 | |
Feb 11 2020 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,750,335 | 0 | 0 | |
Feb 11 2020 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,750,336 | 0 | 0 | |
Feb 11 2020 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 1,338,000 | 0 | 0 | |
Feb 11 2020 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 1,338,000 | 0 | 0 | |
Feb 11 2020 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 4,121,519 | 0 | 4,121,519 | 0 to 4.1 M |
Feb 11 2020 | BEAM | Beam Therapeutics ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 4,121,520 | 0 | 4,121,520 | 0 to 4.1 M |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,222,222 | 0 | 0 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 555,555 | 0 | 0 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 13,333,332 | 0 | 0 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,222,222 | 0 | 0 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 555,555 | 0 | 0 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 13,333,332 | 0 | 0 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 11,111,110 | 0 | 0 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 11,111,110 | 0 | 0 | |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | P | 20.00 | 1,000,000 | 20,000,000 | 1,000,000 | 0 to 1000 K |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | P | 20.00 | 1,000,000 | 20,000,000 | 1,000,000 | 0 to 1000 K |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 15,555,554 | 0 | 15,555,554 | 0 to 15.6 M |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 15,555,554 | 0 | 15,555,554 | 0 to 15.6 M |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 11,666,665 | 0 | 12,111,109 | 444.4 K to 12.1 M (+2,625.00 %) |
Oct 18 2019 | VIR | Vir Biotechnology, ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 11,666,665 | 0 | 12,111,109 | 444.4 K to 12.1 M (+2,625.00 %) |
Aug 12 2019 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 2,030 | 0 | 2,030 | 0 to 2 K |
Aug 12 2019 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Sell | J | 0.00 | 400,000 | 0 | 10,668,749 | 11.1 M to 10.7 M (-3.61 %) |
Jul 02 2019 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 660,501 | 0 | 0 | |
Jul 02 2019 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 660,502 | 0 | 0 | |
Jul 02 2019 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 557,206 | 0 | 0 | |
Jul 02 2019 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 557,207 | 0 | 0 | |
Jul 02 2019 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Buy | P | 16.00 | 100,000 | 1,600,000 | 1,681,435 | 1.6 M to 1.7 M (+6.32 %) |
Jul 02 2019 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Buy | P | 16.00 | 100,000 | 1,600,000 | 1,681,437 | 1.6 M to 1.7 M (+6.32 %) |
Jul 02 2019 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 857,792 | 0 | 1,581,435 | 723.6 K to 1.6 M (+118.54 %) |
Jul 02 2019 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 857,793 | 0 | 1,581,437 | 723.6 K to 1.6 M (+118.54 %) |
Jul 02 2019 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 723,643 | 0 | 724 | -722,919 to 724 (-100.10 %) |
Jul 02 2019 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 723,644 | 0 | 724 | -722,920 to 724 (-100.10 %) |
Jul 01 2019 | KRTX | Karuna Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | A | 16.00 | 16,250 | 260,000 | 16,250 | |
Jun 24 2019 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Option Exercise | A | 9.00 | 25,000 | 225,000 | 25,000 | |
Jun 03 2019 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | A | 19.50 | 27,245 | 531,278 | 27,245 | |
Jun 15 2018 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | A | 18.92 | 27,830 | 526,544 | 27,830 | |
Jun 05 2018 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Option Exercise | A | 15.08 | 10,000 | 150,800 | 10,000 | ||
May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 195,672 | 0 | 0 | |
May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 1,486,745 | 0 | 0 | |
May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,067,160 | 0 | 0 | |
May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 4,228,432 | 0 | 0 | |
May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,030,625 | 0 | 0 | |
May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 195,672 | 0 | 1,682,417 | 1.5 M to 1.7 M (+13.16 %) |
May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 1,486,745 | 0 | 1,486,745 | 0 to 1.5 M |
May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 2,067,160 | 0 | 8,365,764 | 6.3 M to 8.4 M (+32.82 %) |
May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 4,228,432 | 0 | 6,298,604 | 2.1 M to 6.3 M (+204.26 %) |
May 07 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 2,030,625 | 0 | 2,070,172 | 39.5 K to 2.1 M (+5,134.71 %) |
May 04 2018 | UBX | Unity Biotechnolog ... | NELSEN ROBERT | Director | Option Exercise | A | 17.00 | 40,678 | 691,526 | 40,678 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Option Exercise | D | 23.29 | 12,000 | 279,480 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Option Exercise | D | 42.40 | 12,000 | 508,800 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Option Exercise | D | 60.00 | 12,000 | 720,000 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Sell | U | 87.00 | 10,552,390 | 918,057,930 | 0 | 10.6 M to 0 (-100.00 %) |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Sell | D | 87.00 | 3,234 | 281,358 | 0 | 3.2 K to 0 (-100.00 %) |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Sell | U | 87.00 | 50,824 | 4,421,688 | 3,234 | 54.1 K to 3.2 K (-94.02 %) |
Jan 09 2018 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Grant | A | 0.00 | 237 | 0 | 54,058 | 53.8 K to 54.1 K (+0.44 %) |
Dec 12 2017 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 312,500 | 0 | 0 | |
Dec 12 2017 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 375,000 | 0 | 0 | |
Dec 12 2017 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 10,068,749 | 0 | 0 | |
Dec 12 2017 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 10,756,249 | 0 | 11,068,749 | 312.5 K to 11.1 M (+3,442.00 %) |
Dec 08 2017 | DNLI | Denali Therapeutic ... | NELSEN ROBERT | Director | Option Exercise | A | 18.00 | 47,165 | 848,970 | 47,165 | |
Nov 02 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Option Exercise | A | 19.91 | 5,315 | 105,822 | 5,315 | |
Oct 10 2017 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Grant | A | 0.00 | 254 | 0 | 53,821 | 53.6 K to 53.8 K (+0.47 %) |
Aug 01 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 319,421 | 0 | 0 | |
Aug 01 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 211,934 | 0 | 0 | |
Aug 01 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 563,072 | 0 | 0 | |
Aug 01 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,538,641 | 0 | 0 | |
Aug 01 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 319,421 | 0 | 882,493 | 563.1 K to 882.5 K (+56.73 %) |
Aug 01 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 563,072 | 0 | 563,072 | 0 to 563.1 K |
Aug 01 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 211,934 | 0 | 2,750,575 | 2.5 M to 2.8 M (+8.35 %) |
Aug 01 2017 | SNNA | Sienna Biopharmace ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 2,538,641 | 0 | 2,538,641 | 0 to 2.5 M |
Jul 07 2017 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Grant | A | 0.00 | 400 | 0 | 53,567 | 53.2 K to 53.6 K (+0.75 %) |
Jun 19 2017 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Option Exercise | A | 23.29 | 12,000 | 279,480 | 12,000 | |
Jun 12 2017 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Option Exercise | A | 14.26 | 11,000 | 156,860 | 11,000 | |
Apr 06 2017 | JUNO | Juno Therapeutics, ... | NELSEN ROBERT | Director | Grant | A | 0.00 | 573 | 0 | 53,167 | 52.6 K to 53.2 K (+1.09 %) |
Mar 07 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 49.43 | 40 | 1,977 | 0 | 40 to 0 (-100.00 %) |
Mar 07 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 52.15 | 400 | 20,859 | 40 | 440 to 40 (-90.91 %) |
Mar 07 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 51.34 | 8,734 | 448,376 | 440 | 9.2 K to 440 (-95.20 %) |
Mar 07 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 50.69 | 31,425 | 1,592,996 | 9,174 | 40.6 K to 9.2 K (-77.40 %) |
Mar 01 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 50.18 | 20,237 | 1,015,416 | 40,599 | 60.8 K to 40.6 K (-33.26 %) |
Mar 01 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 49.47 | 27,622 | 1,366,400 | 60,836 | 88.5 K to 60.8 K (-31.23 %) |
Mar 01 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 50.28 | 57,488 | 2,890,439 | 88,458 | 145.9 K to 88.5 K (-39.39 %) |
Mar 01 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 49.13 | 83,750 | 4,114,813 | 145,946 | 229.7 K to 145.9 K (-36.46 %) |
Mar 01 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 48.36 | 53,985 | 2,610,828 | 229,696 | 283.7 K to 229.7 K (-19.03 %) |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 36,152 | 0 | 109,230 | 73.1 K to 109.2 K (+49.47 %) |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 25,412 | 0 | 73,078 | 47.7 K to 73.1 K (+53.31 %) |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 48.75 | 8,400 | 409,482 | 283,681 | 292.1 K to 283.7 K (-2.88 %) |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | NELSEN ROBERT | Director | Sell | S | 47.73 | 42,596 | 2,032,979 | 292,081 | 334.7 K to 292.1 K (-12.73 %) |